Wanrudee Isaranuwatchai


Affiliate Scientist


Dr. Wanrudee Isaranuwatchai is a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

She is an Interim Director and a Health Economist at the Centre for Excellence in Economic Analysis Research (CLEAR), a part of the HUB Health Research Solutions at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Isaranuwatchai has collaborated with researchers and decision-makers in various topics areas to help communicate the value of health programs/initiatives using economic evidence. She has experience conducting economic evaluations using person-level data and decision modeling. Dr. Isaranuwatchai’s research focuses on applied economic evaluation (e.g., how to make economic evaluation more useful to researchers, health providers, and decision-makers) and health economics methods.

Recent Publications

  1. Saunders, H, Sujic, R, Bogoch, ER, Jain Che, R, Jinah, A, Elliot-Gibson, V et al.. Cost-Utility Analysis of the Ontario Fracture Screening and Prevention Program. J Bone Joint Surg Am. 2021; :. doi: 10.2106/JBJS.20.00795. PubMed PMID:33764937 .
  2. Shickh, S, Rafferty, SA, Clausen, M, Kodida, R, Mighton, C, Panchal, S et al.. The role of digital tools in the delivery of genomic medicine: enhancing patient-centered care. Genet Med. 2021; :. doi: 10.1038/s41436-021-01112-1. PubMed PMID:33654192 .
  3. Kastner, M, Makarski, J, Hayden, L, Hamid, JS, Holroyd-Leduc, J, Twohig, M et al.. Effectiveness of an eHealth self-management tool for older adults with multimorbidity (KeepWell): protocol for a hybrid effectiveness-implementation randomised controlled trial. BMJ Open. 2021;11 (2):e048350. doi: 10.1136/bmjopen-2020-048350. PubMed PMID:33597147 PubMed Central PMC7893667.
  4. Tangcharoensathien, V, Sirilak, S, Sritara, P, Patcharanarumol, W, Lekagul, A, Isaranuwatchai, W et al.. Co-production of evidence for policies in Thailand: from concept to action. BMJ. 2021;372 :m4669. doi: 10.1136/bmj.m4669. PubMed PMID:33593790 PubMed Central PMC7879270.
  5. Sharma, M, Teerawattananon, Y, Dabak, SV, Isaranuwatchai, W, Pearce, F, Pilasant, S et al.. A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region. Health Res Policy Syst. 2021;19 (1):19. doi: 10.1186/s12961-020-00647-0. PubMed PMID:33573676 PubMed Central PMC7879649.
  6. Benzies, KM, Aziz, K, Shah, V, Faris, P, Isaranuwatchai, W, Scotland, J et al.. Effectiveness of Alberta Family Integrated Care on infant length of stay in level II neonatal intensive care units: a cluster randomized controlled trial. BMC Pediatr. 2020;20 (1):535. doi: 10.1186/s12887-020-02438-6. PubMed PMID:33246430 PubMed Central PMC7697372.
  7. Clausen, M, Mighton, C, Kiflen, R, Sebastian, A, Dai, WF, Mercer, RE et al.. Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectives. CMAJ Open. ;8 (4):E772-E778. doi: 10.9778/cmajo.20200118. PubMed PMID:33234584 PubMed Central PMC7721249.
  8. Wiljer, D, Shi, J, Lo, B, Sanches, M, Hollenberg, E, Johnson, A et al.. Effects of a Mobile and Web App (Thought Spot) on Mental Health Help-Seeking Among College and University Students: Randomized Controlled Trial. J Med Internet Res. 2020;22 (10):e20790. doi: 10.2196/20790. PubMed PMID:33124984 PubMed Central PMC7665949.
  9. Dai, WF, Beca, J, Croxford, R, Isaranuwatchai, W, Menjak, IB, Petrella, TM et al.. Real-world, population-based cohort study of toxicity and resource utilization of second-line ipilimumab for metastatic melanoma in Ontario, Canada. Int J Cancer. 2021;148 (8):1910-1918. doi: 10.1002/ijc.33357. PubMed PMID:33105030 .
  10. Lou, J, Kc, S, Toh, KY, Dabak, S, Adler, A, Ahn, J et al.. Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward. Int J Technol Assess Health Care. 2020;36 (5):474-480. doi: 10.1017/S0266462320000628. PubMed PMID:32928330 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto